Abstract:Jiayu Yue, 1, 2 Ming Yao 2 1 The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University/The Second School of Medicine, Wenzhou Medical University, Wenzhou City, Zhejiang, People's Republic of China; 2 Department of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing or the Affiliated Hospital of Jiaxing University, Jiaxing City, Zhejiang, People's Republic of China Correspondence: Ming Yao, Email Background: The neurocutaneous disease caused by the reactivation of varicella-zoster virus (VZV) is called herpes zoster (HZ). The virus remains in the spinal cord back root after the chickenpox disappears. Diminished immune function can reactivate VZV, causing severe neuropathic pain that can last for months or even years, leading to postherpetic neuralgia (PHN), which severely affects the patient's quality of life. Much literature compares various cytokine levels in the body fluids HZ and PHN patients; however, no studies comprehensively evaluate them. Methods: The Cochrane Library, PubMed, Web of Science, and Medline were screened for studies on cytokine levels in body fluids of HZ and PHN patients in the English language. Healthy individuals were selected as the control group, and the standardized mean difference (SMD) between the case and control groups was imputed using a fixed-effects or random-effects model and expressed as a 95% confidence interval (CI). The Newcastle-Ottawa Scale (NOS) was used to assess article quality. Results: This meta-analysis included 13 articles with 1373 participants. Compared with the control group, the HZ group had significantly higher levels of interleukin (IL)-4, IL-6, IL-10, Hcy, and C-reactive protein (CRP), whereas the levels of CD3+ T and CD4+ T lymphocytes were reduced. Additionally, PHN patients had significantly higher levels of IL-6 and IL-1β compared with the control group. Conclusion: This meta-analysis provides compelling evidence that CRP, Hcy, IL-1β, IL-4, IL-6, IL-8, and IL-10 are associated with the genesis and development of HZ and PHN. These markers can be used to improve the diagnosis and treatment of these diseases.Furthermore, for making the results more convincing, it is necessary to harmonize sample acquisition techniques and analytical methods and also require larger, more rigorously designed studies with broader subgroups and sex/age-matched controls. Keywords: herpes zoster, varicella-zoster virus, neurocutaneous disease, postherpetic neuralgia, biomarker Herpes zoster (HZ) is a disease characterized by skin blisters and nerve pain. When the immune system is compromised, latent varicella-zoster virus (VZV) reactivates in the back root ganglia of the spinal nerve. Age and immunosuppression are the main risk factors of HZ. Approximately one-third of people are at risk for HZ in their lifetime, and nearly half of people ≥ 85 years old develop HZ. 1,2 Zoster-related pain can be classified into acute HZ neuralgia (AHN; within 1 month after the rash) or subacute (SHN; within 3 months after the rash) HZ neuralgia, and postherpetic neuralgia (PHN; more than three months after the rash). 3 The main symptom of PHN is severe and persistent pain, mostly in HZ-infected areas such as the chest, abdomen, face, or neck. The pain can be described as a stabbing, burning, tingling, or electric shock sensation and is often unbearable in severity. 4,5 The etiopathogenesis of HZ is not well known; however, several studies have indicated that it may be associated with immune system dysfunction, 6 impaired oxidative status, 7 and neuroinflammatory response. 8 These factors can be determined using biomarkers, such as CRP, interleukins, lymphocytes, and antioxidant factors. Impaired immune function is closely related to the onset and progression of HZ. 9 Lymphocytes crucially modulate viral infections, and their depletion is associated with viral reactivation. 10 Oxidative stress and inflammation cause tissue damage, and redox regulation is involved in activating or inhibiting the inflammatory response during cellular stress. 11 Pathogen invasion disrupts the body's redox state, causing oxidative stress and promoting inflammation of skin cells, blood, and the central nervous system (CNS). 12 However, the body's natural antioxidants can counteract the damage caused by oxidative stress-related factors. 13 Inflammation depletes antioxidants as they are consumed for the elimination of excess free radicals. 14 C-reactive proteins (CRP) are biomarkers of systemic inflammation 15 and modulate inflammation development and enhance the prevalence of chronic inflammatory -Abstract Truncated-

Reverse Isotopic Phenomenon in Acute Drug Eruption

Wolf’s Isotopic Response after Herpes Zoster Infection: A Study of 24 New Cases and Literature Review

Clinical and immunological phenotype switch to prurigo nodularis in a patient receiving ixekizumab for treating psoriasis: a case report

Wolf's Isotopic Response After Herpes Zoster Infection in Chronic Lichen Sclerosus-Like Graft versus Host Disease: Case Report and Literature Review

Wolf’s Isotopic Response after Herpes Zoster Infection in Chronic Lichen Sclerosus-Like Graft Versus Host Disease: Case Report and Literature Review

Acquired Perforating Dermatosis After Herpes Zoster: Wolf Isotopic Response

Wolf′s isotopic response manifesting as granulomatous inflammation after disseminated herpes zoster: a case report

360 Interface Dermatitis is Characterized by a Type I Immune Response and an Epidermal Reaction to IFN-γ and TNF-α

Penile Granulomas Induced by Isotretinoin

Type I Immune Response Induces Keratinocyte Necroptosis and is Associated with Interface Dermatitis.

An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine

A Case of Psoriasis and Pseudohernia of the Abdominal Wall at the Site of Herpes Zoster-Wolf's Isotopic Response

Acute Localized Exanthematous Pustulosis in a 5-Year-Old Boy With Zosteriform Distrubiton

Detection of varicella‐zoster virus in two dermatomes of herpes zoster duplex bilateralis in an immunocompetent host

Association of CD8 + T lymphocyte repertoire spreading with the severity of DRESS syndrome

Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap

Humoral Cytokine Levels in Patients with Herpes Zoster: A Meta-Analysis

Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Identification of Novel Gene Signatures in Patients with Atopic Dermatitis Complicated by Eczema Herpeticum

Bier Spots Associated with Long COVID.

Clinical Characteristics of Acyclovir-Resistant Herpetic Keratitis and Experimental Studies of Isolates